RL
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.033
Exchange
XSWX - Six Swiss Exchange
0.052 B
Last period Equity ,CHF
145%
Equity has increased in 5 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also Relief Therapeutics
Company Analysis
RLF.SW valuation, rating, competitors, insights and company profile
Eyestock Rating
RLF.SW financial analysis by Eyestock methodology
Valuation
RLF.SW valuation using historical relative method
Statements
RLF.SW Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RLF.SW dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
Relief Therapeutics`s Equity for the period ended 2023-12-31 is 0.052 B CHF
